Sign in
Facet browsing currently unavailable
Page 10 of 1338 results
Sort by: relevance publication year
|
Overexpression of long noncoding RNA LINC01419 in esophageal squamous cell carcinoma and its relation to the sensitivity to 5-fluorouracil by mediating GSTP1 methylation JOURNAL ARTICLE published January 2019 in Therapeutic Advances in Medical Oncology Research funded by Letter from the Third Batch and Fourth Batch of Medical and Health Science and Technology Program Project Funds in Shantou City in 2018 (Shan Fu Ke letter (2018) 238) |
|
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer JOURNAL ARTICLE published January 2018 in Therapeutic Advances in Medical Oncology Research funded by Ministry of Science and Technology, Taiwan (MOST 104-2314-B-006-046-MY3) | Ministry of Science and Technology, Taiwan (MOST105-2314-B-076- MY2) | Ministry of Health and Welfare (MOHW106-TDU-B-211-144-004) | National Cheng Kung University Hospital (NCKUH-10503002) |
|
Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages? JOURNAL ARTICLE published 1 January 2018 in Therapeutic Advances in Medical Oncology |
|
Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer? JOURNAL ARTICLE published 1 January 2018 in Therapeutic Advances in Medical Oncology |
|
Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology Research funded by Natural Science Foundation of Shanghai (13ZR1452800) | Natural Science Foundation of Shanghai (19ZR1431100) | Nurturing Fund of Renji Hospital (PYMDT-002) | shanghai jiao tong university (YG2017QN49) | shanghai jiao tong university (ZH2018QNA42) | shanghai hospital development center (12016231) | shanghai hospital development center (16CR3065B) | Science and Technology Commission of Shanghai Municipality (15JC1402700) | shanghai municipal health and family planning commission (20144Y0218) | shanghai municipal health and family planning commission (201640006) | National Natural Science Foundation of China (81172505) | National Natural Science Foundation of China (81302302) | Shanghai “Rising Stars of Medical Talent” Youth Development Program for Outstanding Youth Medical Talents (2018-16) | Shanghai Collaborative Innovation Center for Translational Medicine (TM201908) | ministry of education of the people’s republic of china (20120071120105) |
|
Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient’s follow up? JOURNAL ARTICLE published May 2015 in Therapeutic Advances in Medical Oncology |
|
Treatment of older patients with colorectal cancer: a perspective review JOURNAL ARTICLE published May 2014 in Therapeutic Advances in Medical Oncology |
|
Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study JOURNAL ARTICLE published January 2024 in Therapeutic Advances in Medical Oncology |
|
Evaluation of efficacy of chemotherapy for mucinous carcinoma: a surveillance, epidemiology, and end results cohort study JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology |
|
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer JOURNAL ARTICLE published January 2021 in Therapeutic Advances in Medical Oncology Research funded by Chang Gung Medical Foundation (CORPG3J0331) |
|
Is flat dosing cost-effective? Re: ‘The same old story’: thoughts on authorised doses of anticancer drugs JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology |
|
Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancer JOURNAL ARTICLE published January 2023 in Therapeutic Advances in Medical Oncology |
|
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma JOURNAL ARTICLE published January 2019 in Therapeutic Advances in Medical Oncology |
|
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts JOURNAL ARTICLE published January 2019 in Therapeutic Advances in Medical Oncology |
|
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience JOURNAL ARTICLE published January 2022 in Therapeutic Advances in Medical Oncology |
|
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study JOURNAL ARTICLE published January 2020 in Therapeutic Advances in Medical Oncology |
|
New combinations and immunotherapies for melanoma: latest evidence and clinical utility JOURNAL ARTICLE published September 2013 in Therapeutic Advances in Medical Oncology |
|
Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis JOURNAL ARTICLE published January 2022 in Therapeutic Advances in Medical Oncology Research funded by danish cancer society research center (R257-A14700) | Health Research Foundation of Central Denmark Region (A1602) |
|
Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs) JOURNAL ARTICLE published January 2021 in Therapeutic Advances in Medical Oncology |
|
Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer JOURNAL ARTICLE published January 2022 in Therapeutic Advances in Medical Oncology |